Faculty Opinions recommendation of The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial.

2012 ◽  
Author(s):  
Todd Allen
Keyword(s):  
Randomised Controlled Trial ◽  
Ischaemic Stroke ◽  
Acute Ischaemic Stroke ◽  
Controlled Trial ◽  
Intravenous Thrombolysis ◽  
Recombinant Tissue Plasminogen Activator ◽  
The Third ◽  
Tissue Plasminogen ◽  
Randomised Controlled ◽  
Stroke Trial

scholarly journals The Norwegian tenecteplase stroke trial (NOR-TEST): randomised controlled trial of tenecteplase vs. alteplase in acute ischaemic stroke

BMC Neurology ◽  
2014 ◽  
Vol 14 (1) ◽  
Author(s):  
Nicola Logallo ◽  
Christopher E Kvistad ◽  
Aliona Nacu ◽  
Halvor Naess ◽  
Ulrike Waje-Andreassen ◽  
...  
Keyword(s):  
Randomised Controlled Trial ◽  
Ischaemic Stroke ◽  
Acute Ischaemic Stroke ◽  
Controlled Trial ◽  
Randomised Controlled ◽  
Stroke Trial
Sign in / Sign up

Export Citation Format

Share Document